Thrombolysis in stroke beyond three hours: Targeting patients with diffusion and perfusion MRI

被引：46
作者：
Warach, S [1 ]
机构：
[1] NINCDS, Bethesda, MD 20892 USA
来源：
ANNALS OF NEUROLOGY | 2002年 / 51卷 / 01期
关键词：
D O I：
10.1002/ana.10109
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：11 / 13
页数：3
相关论文
共 14 条
  • [1] Enlargement of human cerebral ischemic lesion volumes measured by diffusion-weighted magnetic resonance imaging
    Baird, AE
    Benfield, A
    Schlaug, G
    Siewert, B
    Lovblad, KO
    Edelman, RR
    Warach, S
    [J]. ANNALS OF NEUROLOGY, 1997, 41 (05) : 581 - 589
  • [2] Recombinant tissue-type plasminogen activator (alteplase) for ischemic stroke 3 to 5 hours after symptom onset - The ATLANTIS study: A randomized controlled trial
    Clark, WM
    Wissman, S
    Albers, GW
    Jhamandas, JH
    Madden, KP
    Hamilton, S
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (21): : 2019 - 2026
  • [3] Diffusion-weighted MR imaging:: Diagnostic accuracy in patients imaged within 6 hours of stroke symptom onset
    González, RG
    Schaefer, PW
    Buonanno, FS
    Schwamm, LH
    Budzik, RF
    Rordorf, G
    Wang, B
    Sorensen, AG
    Koroshetz, WJ
    [J]. RADIOLOGY, 1999, 210 (01) : 155 - 162
  • [4] Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II)
    Hacke, W
    Kaste, M
    Fieschi, C
    von Kummer, R
    Davalos, A
    Meier, D
    Larrue, V
    Bluhmki, E
    Davis, S
    Donnan, G
    Schneider, D
    Diez-Tejedor, E
    Trouillas, P
    [J]. LANCET, 1998, 352 (9136) : 1245 - 1251
  • [5] HACKE W, 1995, JAMA-J AM MED ASSOC, V274, P1017, DOI 10.1001/jama.274.13.1017
  • [6] Evaluation of early reperfusion and IV tPA therapy using diffusion- and perfusion-weighted MRI
    Marks, MP
    Tong, DC
    Beaulieu, C
    Albers, GW
    de Crespigny, A
    Moseley, ME
    [J]. NEUROLOGY, 1999, 52 (09) : 1792 - 1798
  • [7] TISSUE-PLASMINOGEN ACTIVATOR FOR ACUTE ISCHEMIC STROKE
    MARLER, JR
    BROTT, T
    BRODERICK, J
    KOTHARI, R
    ODONOGHUE, M
    BARSAN, W
    TOMSICK, T
    SPILKER, J
    MILLER, R
    SAUERBECK, L
    JARRELL, J
    KELLY, J
    PERKINS, T
    MCDONALD, T
    RORICK, M
    HICKEY, C
    ARMITAGE, J
    PERRY, C
    THALINGER, K
    RHUDE, R
    SCHILL, J
    BECKER, PS
    HEATH, RS
    ADAMS, D
    REED, R
    KLEI, M
    HUGHES, S
    ANTHONY, J
    BAUDENDISTEL, D
    ZADICOFF, C
    RYMER, M
    BETTINGER, I
    LAUBINGER, P
    SCHMERLER, M
    MEIROSE, G
    LYDEN, P
    RAPP, K
    BABCOCK, T
    DAUM, P
    PERSONA, D
    BRODY, M
    JACKSON, C
    LEWIS, S
    LISS, J
    MAHDAVI, Z
    ROTHROCK, J
    TOM, T
    ZWEIFLER, R
    DUNFORD, J
    ZIVIN, J
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (24) : 1581 - 1587
  • [8] Early stroke treatment associated with better outcome - The NINDS rt-PA Stroke Study
    Marler, JR
    Tilley, BC
    Lu, M
    Brott, TG
    Lyden, PC
    Grotta, JC
    Broderick, JP
    Levine, SR
    Frankel, MP
    Horowitz, SH
    Haley, EC
    Lewandowski, CA
    Kwiatkowski, TP
    [J]. NEUROLOGY, 2000, 55 (11) : 1649 - 1655
  • [9] Diffusion- and perfusion-weighted MRI response to thrombolysis in stroke
    Parsons, MW
    Barber, PA
    Chalk, J
    Darby, DG
    Rose, S
    Desmond, PM
    Gerraty, RP
    Tress, BM
    Wright, PM
    Donnan, GA
    Davis, SM
    [J]. ANNALS OF NEUROLOGY, 2002, 51 (01) : 28 - 37
  • [10] Monitoring intravenous recombinant tissue plasminogen activator thrombolysis for acute ischemic stroke with diffusion and perfusion MRI
    Schellinger, PD
    Jansen, O
    Fiebach, JB
    Heiland, S
    Steiner, T
    Schwab, SF
    Pohlers, O
    Ryssel, H
    Sartor, K
    Hacke, W
    [J]. STROKE, 2000, 31 (06) : 1318 - 1328
12